abstract |
Disclosed herein are combinations of an OX40 modulator, such as an agonist OX40 binding protein, and a TLR4 modulator, such as a TLR4 agonist, pharmaceutical compositions thereof, uses thereof, and methods of treatment comprising administering said combination, including uses in cancer. |